SE8802805L - Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma - Google Patents

Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma

Info

Publication number
SE8802805L
SE8802805L SE8802805A SE8802805A SE8802805L SE 8802805 L SE8802805 L SE 8802805L SE 8802805 A SE8802805 A SE 8802805A SE 8802805 A SE8802805 A SE 8802805A SE 8802805 L SE8802805 L SE 8802805L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
easy
pharmaceutical composition
same
Prior art date
Application number
SE8802805A
Other languages
English (en)
Other versions
SE8802805D0 (sv
Inventor
J Balint
S Jancso
T Farago
J Erdei
I Kovacs
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of SE8802805D0 publication Critical patent/SE8802805D0/sv
Publication of SE8802805L publication Critical patent/SE8802805L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8802805A 1987-08-04 1988-08-03 Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma SE8802805L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (2)

Publication Number Publication Date
SE8802805D0 SE8802805D0 (sv) 1988-08-03
SE8802805L true SE8802805L (sv) 1989-02-05

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802805A SE8802805L (sv) 1987-08-04 1988-08-03 Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma

Country Status (16)

Country Link
JP (1) JPH01117828A (sv)
AU (1) AU612387B2 (sv)
BE (1) BE1001932A4 (sv)
BG (1) BG49522A1 (sv)
CH (1) CH675833A5 (sv)
CS (1) CS274600B2 (sv)
DD (1) DD272414A5 (sv)
DE (1) DE3826419A1 (sv)
ES (1) ES2007544A6 (sv)
FI (1) FI883638A (sv)
FR (1) FR2619011A1 (sv)
GB (1) GB2207865B (sv)
HU (1) HU201683B (sv)
IT (1) IT1226586B (sv)
NL (1) NL8801930A (sv)
SE (1) SE8802805L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230701A (en) * 1988-09-20 1992-01-29 Glaxo Group Ltd Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate
IT1241521B (it) * 1990-07-31 1994-01-17 Polifarma Spa Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (de) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Entbittertes Ranitidin-Präparat
SK20099A3 (en) * 1996-08-16 2000-08-14 Schering Corp Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN103816560B (zh) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 一种用于创口修复的胶体液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
CS543688A2 (en) 1990-10-12
AU612387B2 (en) 1991-07-11
IT1226586B (it) 1991-01-24
FI883638A (fi) 1989-02-05
NL8801930A (nl) 1989-03-01
CH675833A5 (sv) 1990-11-15
FI883638A0 (fi) 1988-08-03
ES2007544A6 (es) 1989-06-16
SE8802805D0 (sv) 1988-08-03
DD272414A5 (de) 1989-10-11
AU2038788A (en) 1989-02-09
FR2619011A1 (fr) 1989-02-10
GB8818575D0 (en) 1988-09-07
BG49522A1 (en) 1991-12-16
IT8821634A0 (it) 1988-08-03
BE1001932A4 (fr) 1990-04-17
CS274600B2 (en) 1991-08-13
GB2207865B (en) 1991-10-09
GB2207865A (en) 1989-02-15
JPH01117828A (ja) 1989-05-10
DE3826419A1 (de) 1989-02-16
HUT47848A (en) 1989-04-28
HU201683B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
FI872864A (sv) Förfarande för framställning av farmaceutiskt aktiva bensimidazolföreningar
SE8804629D0 (sv) New therapeutically active compounds
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
ATE72238T1 (de) Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
SE8802805L (sv) Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2063250T3 (es) Uso de la trombospondina para facilitar la curacion de las heridas.
SE8404065D0 (sv) Novel biologically active compounds
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
PH27446A (en) Compound with gastric acid inhibitory effect
NO873934D0 (no) Fremgangsmaate for forbedret saarheling.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
SE8704049D0 (sv) Novel pharmacological compounds
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8802805-5

Effective date: 19930301

Format of ref document f/p: F